SCHEMBL8420189

SCHEMBL8420189

CCCC(NC(=O)[C@H](C)Nc1ccc(Cl)c(Cl)c1)C(=O)OC.CC[C@H](C)[C@H](NC(=O)[C@H](C)Nc1ccc(Cl)c(Cl)c1)C(=O)OC

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 4/20 0.50
NOS1 P29475 4/20 0.50
NOS2 P35228 4/20 0.50
TAS1R3 Q7RTX0 3/20 0.43
TAS1R1 Q7RTX1 3/20 0.43
ALDH1A1 P00352 3/20 0.42
HTT P42858 1/20 0.42
POLB P06746 2/20 0.40
MAPT P10636 2/20 0.40
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40
PSMB5 P28074 2/20 0.38
PSMB1 P20618 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974091 0.92 NOS3 (0.57) NOS3NOS1NOS2TAS1R3TAS1R1
SCHEMBL7676887 0.92 NOS3 (0.57) NOS3NOS1NOS2TAS1R3TAS1R1
SCHEMBL7679816 0.92 TAS1R3 (0.49) NOS3NOS1NOS2TAS1R3TAS1R1
SCHEMBL7674505 0.92 NOS3 (0.57) NOS3NOS1NOS2TAS1R3TAS1R1
SCHEMBL7674513 0.92 NOS3 (0.57) NOS3NOS1NOS2TAS1R3TAS1R1
SCHEMBL7679822 0.92 TAS1R3 (0.49) NOS3NOS1NOS2TAS1R3TAS1R1
SCHEMBL7975055 0.92 TAS1R3 (0.49) NOS3NOS1NOS2TAS1R3TAS1R1
SCHEMBL8423095 0.88 TAS1R3 (0.49) NOS3NOS1NOS2TAS1R3TAS1R1
SCHEMBL8418928 0.87 NOS2 (0.50) NOS3NOS1NOS2ALDH1A1HTT
SCHEMBL8418925 0.87 NOS2 (0.50) NOS3NOS1NOS2ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0942923-A2 N-(ARYL/HETEROARYL) AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS Elan Pharmaceuticals, Inc. (US) 1999-09-22 EP claimed
WO-1998022493-A2 N-(ARYL/HETEROARYL) AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS ELAN PHARMACEUTICALS, INC. (US) 1998-05-28 WO claimed